Vertebral Compression Fracture Devices Market to Reach US$ 1,905.14 Million, at … – Press Release

[ad_1]

Newark, New Castle, USA, April 13, 2023 (GLOBE NEWSWIRE) — As per the latest study by Growth Plus Reports, the global vertebral compression fracture devices market was valued at US$ 895.5 million in 2022 and is expected to reach 1,905.14 million and register a revenue CAGR of 8.75% by 2031.

The global vertebral compression fracture devices market was valued and expected to rise with a significant revenue share during the forecast period. Devices for treating vertebral compression fractures are used to treat vertebral fractures, which occur when the spine’s vertebrae break or collapse due to osteoporosis and osteoarthritis. 

Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/vertebral-compression-fracture-devices-market/8575

                             Vertebral Compression Fracture Devices Market Scope

Report Attribute Details
Market size value in 2022 US$ 895.5 million
Revenue forecast in 2031 US$ 1,905.14 million
Growth Rate CAGR of 8.75% from 2023 to 2031
Base year for estimation 2022
Forecast Period 2023-2031
Historical Year 2021
Segments covered Product Type, Surgery, End User, and Region.
Regional scope North America, Europe, Asia Pacific, and the Rest of the World (ROW)

Recent Development in Vertebral Compression Fracture Devices Market: 

  • In January 2022, A US$ 1.6 million funding round for SetBone, a firm that developed a special bone cement for treating vertebral fractures and other orthopedic procedures, was oversubscribed.

Key Takeaways: 

  • The growing number of osteoarthritis cases is driving the global market revenue share. 
  • Technical advancements in imaging equipment are propelling market revenue growth. 
  • Large investments and collaborations with market players will likely boost market revenue during the forecast period.

Market Drivers and Restraints: 

The rising prevalence of obesity, giving rise to osteoporosis and osteoarthritis, is driving the global market revenue share for vertebral…

[ad_2]